Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Base editing: advances and therapeutic opportunities
HTML
Details
Locations
Year:
2020
Type:
review
Source:
Nature Reviews Drug Discovery
DOI:
10.1038/s41573-020-0084-6
Authors:
Elizabeth M. Porto,
Alexis C. Komor,
Ian M. Slaymaker,
Gene W. Yeo
Institutions:
University of California San Diego,
Beam Therapeutics (United States)
Language:
English
Topic:
CRISPR and Genetic Engineering
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
green
Funders:
National Eye Institute,
National Institute of General Medical Sciences,
National Institute of Neurological Disorders and Stroke
Awards:
Development of New Genome Editing Agents Using RNA Modifying Enzymes,
Application of RNA-targeting Cas9 to Fuchs' dystrophy,
MOLECULAR BIOPHYSICS TRAINING PROGRAM,
Therapeutic strategies for microsatellite expansion diseases using RNA targeting
OpenAlex ID:
W3093469725
FWCI:
4.766
Cites:
272
Cited by:
508
Related to:
10